Albert Cha
CIK 1397906 · last filed 2023-09-28
Albert Cha is a corporate insider who has filed 27 SEC Form 4 insider transactions across 7 companies since 2007. The most recent filing, for KALV, was dated Sep 28, 2023. Across all open-market trades the lifetime net is +$41.7M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $72.1M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$72.12M
7
27
$41.68M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| KALV | Director | 1,144,179 | $27.00 | $30.89M | $21.85M | 13 | 2023-09-28 |
| BHVN | Director | 2,049,545 | $11.28 | $23.12M | $7.99M | 3 | 2018-05-03 |
| VYNE Therapeutics Inc. (MNLO) Delisted | Director | 2,606,982 | — | — | $5.00M | 1 | 2018-01-29 |
| ACRS | Director | 4,191,397 | $4.32 | $18.11M | $5.15M | 3 | 2016-07-01 |
| Sierra Oncology, Inc. (DNAI) Delisted | Director | 2,064,308 | — | — | $3.74M | 1 | 2015-07-21 |
| ALBIREO PHARMA, INC. (BIOD) Delisted | Director | 1,553,950 | — | — | -$2.05M | 3 | 2008-03-04 |
| BIOFORM MEDICAL INC (BFRM) Delisted | Director | 87,410 | — | — | $0 | 1 | 2007-11-14 |
Recent Filings
27 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-09-28 | KALV | Grant (A) | — | $0 | EDGAR |
| 2023-09-13 | KALV | Mixed | — | -$54.2K | EDGAR |
| 2022-10-17 | KALV | Grant (A) | — | $0 | EDGAR |
| 2021-10-01 | KALV | Grant (A) | — | $0 | EDGAR |
| 2020-11-03 | KALV | Buy (P) | +115,686 | $1.99M | EDGAR |
| 2020-10-02 | KALV | Grant (A) | — | $0 | EDGAR |
| 2019-10-03 | KALV | Grant (A) | — | $0 | EDGAR |
| 2019-07-30 | KALV | Buy (P) | +56,367 | $957.7K | EDGAR |
| 2019-07-19 | KALV | Buy (P) | +61,280 | $1.09M | EDGAR |
| 2018-10-05 | KALV | Grant (A) | — | $0 | EDGAR |